NeoPharm Co Ltd – Strategy, SWOT and Corporate Finance Report

NeoPharm Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

NeoPharm Co Ltd. (NeoPharm) is a manufacturer of skin care products. The company’s product portfolio includes anti-aging cosmeceuticals and foam wash, shampoo, soap, sun block, soothing creams, soothing lotions, foaming cleansers, shampoo, soap, and sun block for atopic, dry and sensitive skin. The company’s products are marketed under Atopalm, Zeroid and Dr. Mle brands. NeoPharm also develops new medicines for treatment of cancer, skin inflammation, asthma, atopic dermatitis and Type II diabetes. Furthermore, NeoPharm’s products and technologies are exported globally. The company operates across China, Thailand, Taiwan, Indonesia, Singapore, Hong Kong, Russia, Ukraine, Germany, and the US. NeoPharm operates as a subsidiary of Aekyung Group. NeoPharm is headquartered in DaeJeon, South Korea.

Scope

– Detailed information on NeoPharm Co Ltd required for business and competitor intelligence needs.

– A study of the major internal and external factors affecting NeoPharm Co Ltd in the form of a SWOT analysis.

– An in-depth view of the business model of N

Reasons to buy

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess NeoPharm Co Ltd as a prospective partner, vendor or supplier.

- Support sal

Companies mentioned

NeoPharm Co Ltd

Table of Contents